We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Avid Bioservices Inc | NASDAQ:CDMO | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.53 | 6.91% | 8.20 | 8.00 | 8.50 | 8.315 | 7.58 | 7.80 | 1,828,606 | 23:22:08 |
From May 2019 to May 2024
NEW YORK, Nov. 20, 2012 /PRNewswire/ --
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.
JDA Software Group Inc.
Levi & Korsinsky is investigating the Board of Directors of JDA Software Group Inc. (NasdaqGS: JDAS) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to RedPrairie Corp. for $45 per share.
Click here to learn more about the investigation http://zlk.9nl.com/jda-software, or call: 877-363-5972.
Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.
For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.
Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between August 30, 2012 and September 26, 2012.
For more information, click here: http://zlk.9nl.com/peregrine-pharmaceuticals-pphm. You have until November 27, 2012 to request that the Court appoint you as lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
Copyright 2012 PR Newswire
1 Year Avid Bioservices Chart |
1 Month Avid Bioservices Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
